Prediction of cardiovascular risk in chronic coronary syndrome using cardiac troponi
Not Applicable
Completed
- Conditions
- Patients with suspected or known atherosclerotic coronary disease and chronic coronary syndrome attending for elective coronary angiographyCirculatory System
- Registration Number
- ISRCTN15620297
- Lead Sponsor
- Accord (United Kingdom)
- Brief Summary
2023 Results article in https://doi.org/10.1016/j.jacc.2023.05.046 (added 01/08/2023)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 4917
Inclusion Criteria
1. Elective angiography for evaluation of chronic coronary disease
2. Pre-procedure blood samples obtained on the same day as the procedure
3. Permanently resident in Scotland
Exclusion Criteria
Does not meet inclusion criteria
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link elevated cardiac troponin to cardiovascular risk in chronic coronary syndrome patients undergoing angiography?
How does cardiac troponin-based risk prediction compare to high-sensitivity troponin T or C-reactive protein in chronic coronary syndrome patients?
Which biomarkers, including cardiac troponin, best predict cardiovascular risk in chronic coronary syndrome patients prior to elective angiography?
Are elevated cardiac troponin levels associated with higher rates of myocardial infarction or heart failure in chronic coronary syndrome patients post-angiography?
What combination biomarkers or therapies enhance cardiovascular risk prediction beyond cardiac troponin in chronic coronary syndrome patients undergoing elective angiography?